Published in Medical Letter on the CDC and FDA, October 26th, 2003
The new device is designed to enable a urologist to vaporize tissue of an enlarged prostate in about 5 minutes, which would make Trimedyne's procedure the shortest of any procedure for such application.
Trimedyne's new UroMAX Side-Firing Laser Needle is covered by two U.S. patents and two pending U.S. patent applications covering the new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA